BRIEF published on 09/11/2024 at 15:05, 2 months 10 days ago EasyJet Directors Purchase Shares Under Employee Share Plan Market Abuse Regulation Share Incentive Plan Director Shareholding EasyJet Equiniti Trustee
PRESS RELEASE published on 09/11/2024 at 15:00, 2 months 10 days ago Director/PDMR Shareholding easyJet plc notified on 11 Sep 2024 of director share purchases under Share Incentive Plan. PDMRs bought 31 shares each at £4.87 PDMR Share Incentive Plan Shareholding EasyJet Plc Director
BRIEF published on 08/13/2024 at 15:05, 3 months 8 days ago Director/PDMR Shareholding at easyJet PDMR Shareholding Directors EasyJet Incentive Plan
PRESS RELEASE published on 08/13/2024 at 15:00, 3 months 8 days ago Director/PDMR Shareholding easyJet plc notified the purchase of ordinary shares by the Trustee for persons discharging managerial responsibilities as part of the Share Incentive Plan Ordinary Shares Share Incentive Plan EasyJet Plc Trustee Managers
BRIEF published on 07/17/2024 at 17:05, 4 months 4 days ago EasyJet Announces Director/PDMR Shareholding Shareholding Managerial Responsibilities EasyJet Options SAVE Scheme
PRESS RELEASE published on 07/17/2024 at 17:00, 4 months 4 days ago Director/PDMR Shareholding easyJet plc grants options to PDMRs to purchase ordinary shares under the Save As You Earn scheme. Options exercisable for 6 months from maturity date Ordinary Shares EasyJet Plc PDMR Shareholding Options Save As You Earn Scheme
BRIEF published on 07/11/2024 at 15:05, 4 months 10 days ago EasyJet Announces Director/PDMR Shareholding PDMR Director Shareholding EasyJet
PRESS RELEASE published on 07/11/2024 at 15:00, 4 months 10 days ago Director/PDMR Shareholding easyJet plc notified of Director/PDMR Shareholding purchase of ordinary shares by Equiniti Share Plan Trustees Limited on behalf of key personnel. HM Revenue and Customs approved plan details provided PDMR Share Incentive Plan EasyJet Plc Director Equiniti Share Plan Trustees Limited
BRIEF published on 06/11/2024 at 16:50, 5 months 10 days ago EasyJet Announces Director/PDMR Shareholding Updates Shares Director EasyJet Market Regulation Incentive Plan
PRESS RELEASE published on 06/11/2024 at 16:45, 5 months 10 days ago Director/PDMR Shareholding easyJet plc announced purchases of ordinary shares by directors and PDMRs under the Share Incentive Plan, in compliance with Market Abuse Regulation Ordinary Shares PDMR Share Incentive Plan EasyJet Plc Directors
Published on 11/21/2024 at 17:35, 1 hour 3 minutes ago 1upHealth Ranked Number 43 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500(TM)
Published on 11/21/2024 at 17:30, 1 hour 8 minutes ago SimpliGov and Proof Partner to Offer Online Notarization
Published on 11/21/2024 at 16:30, 2 hours 8 minutes ago The Rise of DINKs: Dual-Income Couples Without Kids Redefine Financial Priorities in America
Published on 11/21/2024 at 16:01, 2 hours 37 minutes ago Career Certified Extends Its Investment in the Fast-Growing Architecture, Engineering, and Construction (AEC) Professionals Market with Acquisition of My Contractors License
Published on 11/21/2024 at 16:00, 2 hours 38 minutes ago Financial Independence Group Announces Exclusive Partnership With Power of Zero and Tax-Free Retirement Expert David McKnight
Published on 11/21/2024 at 17:51, 46 minutes ago LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 46 minutes ago 2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.
Published on 11/21/2024 at 15:41, 2 hours 56 minutes ago Edison issues report on Murray Income Trust (MUT)
Published on 11/21/2024 at 06:58, 11 hours 40 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 23 hours 18 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 10 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
